Global Monoclonal Antibodies (mAbs) Market 2020-2030 by Source (Human, Humanized, Chimeric, Murine), Category (Branded, Biosimilar), Production Type (In Vitro, In Vivo), Application (Cancer, Autoimmune, Inflammatory), End User, and Region: Trend Forecast and Growth Opportunity

  • Product Code:
    RP-ID-10352320
  • Published Date:
    7 Jan 2022
  • Region:
    Global
  • Pages:
    165
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-26

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

The Research Report is Updated with 2020 Base Year, 2021 Estimated year and Forecast till 2030 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2020 as base year, 2021 as estimated year and forecast to 2030. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Global monoclonal antibodies market will reach $329.6 billion by 2030, growing by 10.9% annually over 2020-2030, driven by the increasing incidences of new cancer cases and other diseases, growth in geriatric population, increasing pharmaceutical R&D spending, upsurge in healthcare expenditure, and the rising adoption of cost-efficient biosimilar monoclonal antibodies.
Highlighted with 83 tables and 84 figures, this 165-page report “Global Monoclonal Antibodies (mAbs) Market 2020-2030 by Source (Human, Humanized, Chimeric, Murine), Category (Branded, Biosimilar), Production Type (In Vitro, In Vivo), Application (Cancer, Autoimmune, Inflammatory), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global monoclonal antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global monoclonal antibodies market in every aspect of the classification from perspectives of Source, Category, Production Type, Application, End User, and Region.

Based on Source, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Human
• Humanized
• Chimeric
• Murine

Based on Category, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Branded mAbs
• Biosimilar mAbs

Based on Production Type, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• In Vitro Production
• In Vivo Production

Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Cancer
o Breast Cancer
o Colorectal Cancer
o Lung Cancer
o Ovarian Cancer
o Other Cancer Types
• Autoimmune Diseases
• Inflammatory Diseases
• Infectious Diseases
• Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Hospitals
• Research Institutes
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ bn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Source, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
AbbVie, Inc.
Amgen Inc.
AstraZeneca plc
Bayer AG
Bristol-Myers Squibb Company
Eli Lilly
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co., Inc.
Mylan N.V
Norvatis AG
Pfizer
Sanofi S.A.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39
3 Segmentation of Global Market by Source 43
3.1 Market Overview by Source 43
3.2 Human 45
3.3 Humanized 46
3.4 Chimeric 47
3.5 Murine 48
4 Segmentation of Global Market by Category 49
4.1 Market Overview by Category 49
4.2 Branded mAbs 51
4.3 Biosimilar mAbs 52
5 Segmentation of Global Market by Production Type 53
5.1 Market Overview by Production Type 53
5.2 In Vitro Production 55
5.3 In Vivo Production 56
6 Segmentation of Global Market by Application 57
6.1 Market Overview by Application 57
6.2 Cancer 59
6.2.1 Breast Cancer 61
6.2.2 Colorectal Cancer 62
6.2.3 Lung Cancer 63
6.2.4 Ovarian Cancer 64
6.2.5 Other Cancer Types 65
6.3 Autoimmune Diseases 66
6.4 Inflammatory Diseases 67
6.5 Infectious Diseases 68
6.6 Other Applications 69
7 Segmentation of Global Market by End User 70
7.1 Market Overview by End User 70
7.2 Hospitals 72
7.3 Research Institutes 73
7.4 Other End Users 74
8 Segmentation of Global Market by Region 75
8.1 Geographic Market Overview 2019-2030 75
8.2 North America Market 2019-2030 by Country 79
8.2.1 Overview of North America Market 79
8.2.2 U.S. 83
8.2.3 Canada 86
8.2.4 Mexico 88
8.3 European Market 2019-2030 by Country 90
8.3.1 Overview of European Market 90
8.3.2 Germany 94
8.3.3 U.K. 96
8.3.4 France 98
8.3.5 Spain 100
8.3.6 Italy 102
8.3.7 Russia 104
8.3.8 Rest of European Market 106
8.4 Asia-Pacific Market 2019-2030 by Country 108
8.4.1 Overview of Asia-Pacific Market 108
8.4.2 Japan 112
8.4.3 China 115
8.4.4 Australia 117
8.4.5 India 119
8.4.6 South Korea 121
8.4.7 Rest of APAC Region 123
8.5 South America Market 2019-2030 by Country 125
8.5.1 Argentina 128
8.5.2 Brazil 130
8.5.3 Chile 132
8.5.4 Rest of South America Market 134
8.6 MEA Market 2019-2030 by Country 135
8.6.1 UAE 138
8.6.2 Saudi Arabia 140
8.6.3 South Africa 142
8.6.4 Other National Markets 144
9 Competitive Landscape 145
9.1 Overview of Key Vendors 145
9.2 New Product Launch, Partnership, Investment, and M&A 148
9.3 Company Profiles 149
Abbott Laboratories 149
AbbVie, Inc. 151
Amgen Inc. 152
AstraZeneca plc 153
Bayer AG 154
Bristol-Myers Squibb Company 155
Eli Lilly 156
F. Hoffmann-La Roche Ltd. 157
GlaxoSmithKline Plc 158
Johnson & Johnson 159
Merck & Co., Inc. 160
Mylan N.V 161
Norvatis AG 162
Pfizer 163
Sanofi S.A. 164
RELATED REPORTS 165

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
AbbVie, Inc.
Amgen Inc.
AstraZeneca plc
Bayer AG
Bristol-Myers Squibb Company
Eli Lilly
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co., Inc.
Mylan N.V
Norvatis AG
Pfizer
Sanofi S.A.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports